Bionovate Technologies (BIIO) 10-Q 23 Nov 20 2021 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Sep. 30, 2020	Oct. 26, 2020
Cover [Abstract]
Entity Registrant Name	BIONOVATE TECHNOLOGIES CORP.
Entity Central Index Key	0001575420
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Sep. 30, 2020
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2021
Entity Common Stock Shares Outstanding		59,423,598
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Sep. 30, 2020	Jun. 30, 2020
Current Assets
Cash	$ 0	$ 0
Total Current Assets	0	0
TOTAL ASSETS	0	0
Current Liabilities
Accounts payable and accrued liabilities	230,324	211,290
Due to related party	3,840	0
Convertible notes payable	185,375	185,375
Total Current Liabilities	419,539	396,665
TOTAL LIABILITIES	419,539	396,665
Stockholders' Deficit
Preferred stock: 90,000,000 authorized; $0.0001 par value - no shares issued and outstanding	0	0
Common stock: 100,000,000 authorized; $0.0001 par value 59,423,598 and 59,423,598 shares issued and outstanding	5,942	5,942
Additional paid in capital	2,295,633	2,295,633
Accumulated deficit	(2,721,114)	(2,698,240)
Total Deficit	(419,539)	(396,665)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 0	$ 0

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2020	Jun. 30, 2020	Jun. 30, 2019
Stockholders' Deficit
Preferred stock, shares par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	90,000,000	90,000,000	90,000,000
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Common stock, shares par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, shares issued	59,423,598	59,423,598	59,423,598
Common stock, shares outstanding	59,423,598	59,423,598	59,423,598

STATEMENT OF OPERATIONS (Unaudi

STATEMENT OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
STATEMENT OF OPERATIONS (Unaudited)
Revenues	$ 0	$ 0
Operating Expenses
Professional	3,622	13,412
Total operating expenses	3,622	13,412
Net loss from operations	(3,622)	(13,412)
Other income (expense)
Realized foreign currency gain	0	68
Interest expense	(19,252)	(16,032)
Total other expense	(19,252)	(15,964)
Net loss before taxes	(22,874)	(29,376)
Net loss	$ (22,874)	$ (29,376)
Basic and dilutive loss per share
Net loss	$ 0	$ 0
Weighted average number of shares outstanding	59,423,598	15,579,749

STATEMENT OF STOCKHOLDERS DEFIC

STATEMENT OF STOCKHOLDERS DEFICIT (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Balance, shares at Jun. 30, 2019		155,798
Balance, amount at Jun. 30, 2019	$ (332,289)	$ 15	$ 2,243,891	$ (2,576,195)
Beneficial conversion feature	526	0	526	0
Net loss	(29,376)	$ 0	0	(29,376)
Balance, shares at Sep. 30, 2019		155,798
Balance, amount at Sep. 30, 2019	(361,139)	$ 15	2,244,417	(2,605,571)
Balance, shares at Jun. 30, 2020		59,423,598
Balance, amount at Jun. 30, 2020	(396,665)	$ 5,942	2,295,633	(2,698,240)
Net loss	(22,874)
Net loss	(22,874)	$ 0	0	(22,874)
Balance, shares at Sep. 30, 2020		59,423,598
Balance, amount at Sep. 30, 2020	$ (419,539)	$ 5,942	$ 2,295,633	$ (2,721,114)

STATEMENT OF CASH FLOWS (Unaudi

STATEMENT OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (22,874)	$ (29,376)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Expenses paid by convertible notes	0	526
Expenses paid by related party	3,840	0
Amortization of debt discount	0	526
Foreign currency adjustment	0	(68)
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities	19,034	28,392
Net cash provided by operating activities	0	0
Net change in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Supplemental cash flow information
Cash paid for interest	0	0
Cash paid for taxes	0	0
Non-cash transactions:
Beneficial conversion feature	$ 0	$ 526

NATURE AND CONTINUANCE OF OPERA

NATURE AND CONTINUANCE OF OPERATIONS	3 Months Ended
	Sep. 30, 2020
NATURE AND CONTINUANCE OF OPERATIONS
NOTE 1 - NATURE AND CONTINUANCE OF OPERATIONS	Bionovate Technologies Corp. (the “Company”, or the “Corporation”) was incorporated in the state of Nevada, United States on October 24, 2012 under the name MJP International Ltd. On December 1, 2017, the Company’s corporate name was changed to Bionovate Technologies Corp. The Corporation was formed and organized to capitalize on new opportunities found in the North American market for light-emitting diode (“LED”) lighting. With China as the manufacturing backbone of future LED products, the Corporation has set up an office in Guangzhou, China in search of high-quality products offered by reputable manufacturers to be introduced to Canada, the United States, and abroad. The Corporation has set out further details of the acquisition below as well as in Notes 3 and 4 to these consolidated financial statements. On October 7, 2020, Bionovate Technologies Corp. (the “Company”) entered into a Share Exchange Agreement (the “Share Exchange Agreement”) facilitated between Evergreen Solutions, Ltd, a private Company (“Evergreen”), and Human Data AG, a private Switzerland Company (“Human Data”). Pursuant to the Share Exchange Agreement, in exchange for the acquisition of all of the outstanding Company shares which Evergreen owns, to wit, 54,270,000 shares (the “Exchange Shares”), the Company will receive 12,500 shares of Digital Diagnostics AG (“Digital”) owned by Human Data, which equates to 25% of the currently issued shares of Digital. The Share Exchange Agreement contains customary representations and warranties made by the Company, on the one hand, and Evergreen and Human Data on the other hand, made solely for the benefit of the other, which in certain cases are subject to specified exceptions and qualifications contained in the Share Exchange Agreement or in information provided pursuant to certain disclosure schedules to the Share Exchange Agreement GOING CONCERN The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has an accumulated deficit at September 30, 2020 of $2,721,114, is in a net liability position and needs cash to maintain its operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company’s continued existence is dependent upon management’s ability to develop profitable operations, continued contributions from the Company’s executive officers to finance its operations and the ability to obtain additional funding sources to explore potential strategic relationships and to provide capital and other resources for the further development and marketing of the Company’s products and business.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Sep. 30, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions for Form 10-Q and Article 210 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal recurring nature. Operating results for the three months ended September 30, 2020, are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2021. For further information, refer to the financial statements and footnotes thereto included in the Corporation’s filed Form 10-K for the year ended June 30, 2020. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect application of policies and the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the year. Actual results could differ from these estimates. Estimates and their underlying assumptions are reviewed on an ongoing basis. Changes in estimates are recorded in the accounting period in which they are determined. The critical accounting estimates and assumptions in the accompanying unaudited condensed interim financial statements include the provision for unpaid loss and loss adjustment expenses which may result from product warranty provisions; valuation of deferred income taxes; valuation and impairment assessment of intangible assets; goodwill recoverability; and deferred acquisition costs. Fair Value of Financial Instrument The Corporation follows FASB ASC 820, Fair Value Measurements and Disclosures, for all financial instruments and non-financial instruments accounted for at fair value on a recurring basis. This new accounting standard establishes a single definition of fair value and a framework for measuring fair value, sets out a fair value hierarchy to be used to classify the source of information used in fair value measurement and expands disclosures about fair value measurements required under other accounting pronouncements. It does not change existing guidance as to whether or not an instrument is carried at fair value. The Corporation defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Corporation considers the principal or most advantageous market in which the Corporation would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk. The Corporation applies FASB ASC 825, Financial Instruments, which allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. The Corporation has not elected the fair value option for any eligible financial instruments. Basic and Diluted Loss per Common Stock FASB ASC 260 requires dual presentation of basic and diluted earnings per share (EPS) with a reconciliation of the numerator and denominator of the EPS computations. Basic earnings per share amounts are based on the weighted average shares of common stock outstanding. If applicable, diluted earnings per stock would assume the conversion, exercise or issuance of all potential common stock instruments such as options, warrants and convertible securities, unless the effect is to reduce a loss or increase earnings per share. Diluted net income (loss) per common stock on the potential exercise of the equity-based financial instruments is not presented where anti-dilutive. For the three months ended September 30, 2020 and 2019, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. September 30, September 30, 2020 2019 (shares) (shares) Convertible notes 26,740,500 24,575,800

ACCOUNTS PAYABLE AND ACCRUED LI

ACCOUNTS PAYABLE AND ACCRUED LIABILITEIS	3 Months Ended
	Sep. 30, 2020
ACCOUNTS PAYABLE AND ACCRUED LIABILITEIS
NOTE 3 - ACCOUNTS PAYABLE AND ACCRUED LIABILITEIS	AS of September 30, 2020, and June 30, 2020, accounts payable and accrued liabilities consisted of as follows, September 30, June 30, 2020 2020 Accounts payable $ 38,138 $ 25,702 Accrued expenses - 12,654 Accrued interest 151,161 131,909 Due to a former related party 41,025 41,025 $ 230,324 $ 211,290

CONVERTIBLE NOTE

CONVERTIBLE NOTE	3 Months Ended
	Sep. 30, 2020
CONVERTIBLE NOTE
NOTE 4 - CONVERTIBLE NOTE	Convertible notes payable at September 30, 2020 and June 30,2020, consists of the following: September 30, June 30, 2020 2020 Dated November 1, 2016 $ 4,439 $ 4,439 Dated January 1, 2017 - 1 - - Dated January 1, 2017 - 2 - - Dated June 30, 2017 9,969 9,969 Dated April 1, 2018 - 1 10,000 10,000 Dated April 1, 2018 - 2 10,000 10,000 Dated June 30, 2018 28,376 28,376 Dated July 5, 2018 - 1 30,000 30,000 Dated July 5, 2018 - 2 15,000 15,000 Dated July 5, 2018 - 3 15,000 15,000 Dated December 31, 2018 17,302 17,302 Dated March 31, 2019 1,000 1,000 Dated June 30, 2019 17,037 17,037 Dated September 30, 2019 526 526 Dated December 31, 2019 18,892 18,892 Dated March 31, 2020 5,834 5,834 Dated June 30, 2020 2,000 2,000 Total convertible notes payable 185,375 185,375 Less: Unamortized debt discount - - Total convertible notes 185,375 185,375 Less: current portion of convertible notes 185,375 185,375 Long-term convertible notes $ - $ - For the three months ended September 30, 2020 and 2019, the Company recognized interest expense of $19,252 and $15,506 and amortization of discount, included in interest expense, of $0 and $526, respectively. As of September 30, 2020, and June 30, 2020, the Company recorded accrued interest of $151,161 and $131,909, respectively Dated November 1, 2016 On November 1, 2016, the Company issued a convertible note with a conversion price of $0.005 to extinguish debt of $18,239. The convertible note is unsecured, bears interest at 4% per annum and due and payable on November 1, 2017. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $18,239. Dated June 30, 2017 On June 30, 2017, the Company issued a convertible note with a conversion price of $0.01 to pay operating expenses of $9,969. The convertible note is unsecured, bears interest at 35% per annum, has no maturity date and due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $9,969. Dated April 1, 2018 – 1 and 2 On April 1, 2018, the Company issued 2 convertible notes totaling of $20,000 with a conversion price of $$0.01 to pay a purchase of a patent of $10,000. The convertible note is unsecured, bears interest at 45% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $20,000. Dated June 30, 2018 On June 30, 2018, the Company issued a convertible note with a conversion price of $0.01 to pay operating expenses of $28,376. The convertible note is unsecured, bears interest at 30% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $28,376. Dated July 5, 2018 – 1, 2 and 3 On June 30, 2018, the Company issued 3 convertible notes totaling of $60,000 with a conversion price of $0.01 to extinguish amounts due to related parties of $145,523. The convertible notes are unsecured, bears interest at 30% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible notes due to a beneficial conversion feature of $60,000. Dated December 31, 2018 On December 31, 2018, the Company issued a convertible note with a conversion price of $0.005 to pay operating expenses of $17,302. The convertible note is unsecured, bears interest at 35% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible notes due to a beneficial conversion feature of $17,302. Dated March 31, 2019 On March 31, 2019, the Company issued a convertible note with a conversion price of $0.01 to pay operating expenses of $6,427. The convertible note is unsecured, bears interest at 20% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible notes due to a beneficial conversion feature of $6,427. Effective January 28, 2020, the Company amended a convertible note. The Note reduces the interest rate from 20% to 0 and changes the conversion price from $0.01 to $0.0001. Effective January 28, 2020, the Note of $6,427 was assigned to Evergreen Solutions Ltd., and $5,427 was immediately converted for the issuance of 54,270,000 shares of common stock of the Company resulting in a change of control. Dated June 30, 2019 On June 30, 2019, the Company issued a convertible note with a conversion price of $0.005 to pay operating expenses of $17,037. The convertible note is unsecured, bears interest at 35% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible notes due to a beneficial conversion feature of $17,037. Dated September 30, 2019 On September 30, 2019, the Company issued a convertible note with a conversion price of $0.005 to pay operating expenses of $526. The convertible note is unsecured, bears interest at 35% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible notes due to a beneficial conversion feature of $526. Dated December 31, 2019 On December 31, 2019, the Company issued a convertible note with a conversion price of $0.005 to pay operating expenses of $18,892. The convertible note is unsecured, bears interest at 35% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible notes due to a beneficial conversion feature of $18,892. Dated March 31, 2020 On March 31, 2020, the Company issued a convertible note with a conversion price of $0.005 to pay operating expenses of $5,834. The convertible note is unsecured, bears interest at 35% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible notes due to a beneficial conversion feature of $5,834. Dated June 30, 2020 On June 30, 2020, the Company issued a convertible note with a conversion price of $0.001 to pay operating expenses of $2,000. The convertible note is unsecured, bears interest at 35% per annum, has no maturity date and is due on demand. The Company recorded a discount on the convertible notes due to a beneficial conversion feature of $2,000.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Sep. 30, 2020
RELATED PARTY TRANSACTIONS
NOTE 5 - RELATED PARTY TRANSACTIONS	During the three months ended September 30, 2020, the Company’s sole officer paid $3,840 for operating expenses on behalf of the Company. As of September 30, 2020, the Company was obligated to the officer, for an unsecured, non-interest-bearing demand loan with a balance of $3,840.

EQUITY

EQUITY	3 Months Ended
	Sep. 30, 2020
EQUITY
NOTE 6 - EQUITY	Preferred Stock The Company is authorized to issue 90,000,000 shares of preferred stock at a par value of $0.0001. No shares were issued and outstanding as of September 30, 2020 and June 30,2020, respectively. Common Stock The Company is authorized to issue 100,000,000 shares of preferred stock at a par value of $0.0001. As at September 30, 2020 and June 30, 2020, 59,423,598 shares of common stock were issued and outstanding. As at September 30, 2020, there were no warrants or options outstanding.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Sep. 30, 2020
SUBSEQUENT EVENTS
NOTE 7 - SUBSEQUENT EVENTS	Management has evaluated subsequent events through the date these financial statements were available to be issued. Based on our evaluation no material events have occurred that require disclosure.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Sep. 30, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis Of Presentation	The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions for Form 10-Q and Article 210 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal recurring nature. Operating results for the three months ended September 30, 2020, are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2021. For further information, refer to the financial statements and footnotes thereto included in the Corporation’s filed Form 10-K for the year ended June 30, 2020. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect application of policies and the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the year. Actual results could differ from these estimates. Estimates and their underlying assumptions are reviewed on an ongoing basis. Changes in estimates are recorded in the accounting period in which they are determined. The critical accounting estimates and assumptions in the accompanying unaudited condensed interim financial statements include the provision for unpaid loss and loss adjustment expenses which may result from product warranty provisions; valuation of deferred income taxes; valuation and impairment assessment of intangible assets; goodwill recoverability; and deferred acquisition costs.
Fair Value of Financial Instrument	The Corporation follows FASB ASC 820, Fair Value Measurements and Disclosures, for all financial instruments and non-financial instruments accounted for at fair value on a recurring basis. This new accounting standard establishes a single definition of fair value and a framework for measuring fair value, sets out a fair value hierarchy to be used to classify the source of information used in fair value measurement and expands disclosures about fair value measurements required under other accounting pronouncements. It does not change existing guidance as to whether or not an instrument is carried at fair value. The Corporation defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Corporation considers the principal or most advantageous market in which the Corporation would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk. The Corporation applies FASB ASC 825, Financial Instruments, which allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. The Corporation has not elected the fair value option for any eligible financial instruments.
Basic and Diluted Loss per Common Stock	FASB ASC 260 requires dual presentation of basic and diluted earnings per share (EPS) with a reconciliation of the numerator and denominator of the EPS computations. Basic earnings per share amounts are based on the weighted average shares of common stock outstanding. If applicable, diluted earnings per stock would assume the conversion, exercise or issuance of all potential common stock instruments such as options, warrants and convertible securities, unless the effect is to reduce a loss or increase earnings per share. Diluted net income (loss) per common stock on the potential exercise of the equity-based financial instruments is not presented where anti-dilutive. For the three months ended September 30, 2020 and 2019, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. September 30, September 30, 2020 2019 (shares) (shares) Convertible notes 26,740,500 24,575,800

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Sep. 30, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
Schedule of diluted net loss per share	September 30, September 30, 2020 2019 (shares) (shares) Convertible notes 26,740,500 24,575,800

ACCOUNTS PAYABLE AND ACCRUED _2

ACCOUNTS PAYABLE AND ACCRUED LIABILITEIS (Tables)	3 Months Ended
	Sep. 30, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
Schedule of accounts payable and accrued liabilities	September 30, June 30, 2020 2020 Accounts payable $ 38,138 $ 25,702 Accrued expenses - 12,654 Accrued interest 151,161 131,909 Due to a former related party 41,025 41,025 $ 230,324 $ 211,290

CONVERTIBLE NOTE (Tables)

CONVERTIBLE NOTE (Tables)	3 Months Ended
	Sep. 30, 2020
CONVERTIBLE NOTE
Schedule of convertible note payable	September 30, June 30, 2020 2020 Dated November 1, 2016 $ 4,439 $ 4,439 Dated January 1, 2017 - 1 - - Dated January 1, 2017 - 2 - - Dated June 30, 2017 9,969 9,969 Dated April 1, 2018 - 1 10,000 10,000 Dated April 1, 2018 - 2 10,000 10,000 Dated June 30, 2018 28,376 28,376 Dated July 5, 2018 - 1 30,000 30,000 Dated July 5, 2018 - 2 15,000 15,000 Dated July 5, 2018 - 3 15,000 15,000 Dated December 31, 2018 17,302 17,302 Dated March 31, 2019 1,000 1,000 Dated June 30, 2019 17,037 17,037 Dated September 30, 2019 526 526 Dated December 31, 2019 18,892 18,892 Dated March 31, 2020 5,834 5,834 Dated June 30, 2020 2,000 2,000 Total convertible notes payable 185,375 185,375 Less: Unamortized debt discount - - Total convertible notes 185,375 185,375 Less: current portion of convertible notes 185,375 185,375 Long-term convertible notes $ - $ -

NATURE AND CONTINUANCE OF OPE_2

NATURE AND CONTINUANCE OF OPERATIONS (Details Narrative) - USD ($)	1 Months Ended
	Oct. 07, 2020	Sep. 30, 2020	Jun. 30, 2020
Accumulated deficit		$ (2,721,114)	$ (2,698,240)
Digital Diagnostics AG [Member] | Evergreen Solutions Ltd. [Member] | Share Exchange Agreement [Member]
Acqusition of shares, amount	$ 12,500
Percentage of shares acquired	25.00%
Acqusition of shares	54,270,000

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details ) - shares	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
NATURE AND CONTINUANCE OF OPERATIONS
Convertible notes	26,740,500	24,575,800

ACCOUNTS PAYABLE AND ACCRUED _3

ACCOUNTS PAYABLE AND ACCRUED LIABILITEIS (Details) - USD ($)	Sep. 30, 2020	Jun. 30, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
Accounts payable	$ 38,138	$ 25,702
Accrued expense	0	12,654
Accrued interest	151,161	131,909
Due to a former related party	41,025	41,025
Total	$ 230,324	$ 211,290

CONVERTIBLE NOTE (Details)

CONVERTIBLE NOTE (Details) - USD ($)	Sep. 30, 2020	Jun. 30, 2020	Jan. 28, 2020
Total convertible notes payable	$ 185,375	$ 185,375
Less: Unamortized debt discount	0	0
Total convertible notes	185,375	185,375
Less: current portion of convertible notes	185,375	185,375
Long-term convertible notes	0	0
November 1, 2016 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	4,439	4,439
January 1, 2017 - 1 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	0	0
January 1, 2017 - 2 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	0	0
June 30, 2017 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	9,969	9,969
April 1, 2018 - 1 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	10,000	10,000
April 1, 2018 - 2 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	10,000	10,000
June 30, 2018 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	28,376	28,376
July 5, 2018 - 1 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	30,000	30,000
July 5, 2018 - 2 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	15,000	15,000
July 5, 2018 - 3 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	15,000	15,000
December 31, 2018 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	17,302	17,302
March 31, 2019 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	6,427	1,000	$ 6,427
June 30, 2019 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	17,037	17,037
September 30, 2019 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	526	526
December 31, 2019 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	18,892	18,892
March 31, 2020 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	5,834	5,834
June 30, 2020 [Member] | Convertible Notes Payable [Member]
Total convertible notes payable	$ 2,000	$ 2,000

CONVERTIBLE NOTE (Details Narra

CONVERTIBLE NOTE (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Jan. 28, 2020	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020
Interest expenses		$ 19,252	$ 15,506
Amortization of debt discount		0	526
Accrued interest		$ 151,161		$ 131,909
Beneficial conversion feature			$ 526
Common stock shares issued upon conversion of debt, shares		26,740,500	24,575,800
Convertible Notes payable		$ 185,375		185,375
Evergreen Solutions Ltd. [Member]
Common stock shares issued upon conversion of debt, shares	54,270,000
November 1, 2016 [Member] | Convertible Notes Payable [Member]
Convertible note conversion price		$ 0.005
Extinguisment of debt		$ 18,239
Beneficial conversion feature		$ 18,239
Convertible note bearing interest		4.00%
Maturity date		Nov. 1, 2017
Convertible Notes payable		$ 4,439		4,439
June 30, 2017 [Member] | Convertible Notes Payable [Member]
Convertible note conversion price		$ 0.01
Beneficial conversion feature		$ 9,969
Convertible note bearing interest		35.00%
Operating expenses		$ 9,969
Convertible Notes payable		$ 9,969		9,969
June 30, 2018 [Member] | Convertible Notes Payable [Member]
Convertible note conversion price		$ 0.01
Beneficial conversion feature		$ 28,376
Convertible note bearing interest		30.00%
Operating expenses		$ 28,376
Convertible Notes payable		28,376		28,376
July 5, 2018 - 1 [Member] | Convertible Notes Payable [Member]
Debt conversion, converted instrument, principal amount		$ 60,000
Convertible note conversion price		$ 0.001
Extinguisment of debt		$ 145,523
Beneficial conversion feature		60,000
Convertible Notes payable		$ 30,000		30,000
December 31, 2018 [Member] | Convertible Notes Payable [Member]
Convertible note conversion price		$ 0.005
Beneficial conversion feature		$ 17,302
Convertible note bearing interest		35.00%
Operating expenses		$ 17,302
Convertible Notes payable		$ 17,302		17,302
March 31, 2019 [Member] | Convertible Notes Payable [Member]
Debt conversion, converted instrument, principal amount	$ 5,427
Convertible note conversion price	$ 0.0001	$ 0.01
Beneficial conversion feature	$ 6,427	$ 6,427
Convertible note bearing interest	0.00%	20.00%
Convertible Notes payable	$ 6,427	$ 6,427		1,000
June 30, 2019 [Member] | Convertible Notes Payable [Member]
Convertible note conversion price		$ 0.005
Beneficial conversion feature		$ 17,037
Convertible note bearing interest		35.00%
Operating expenses		$ 17,037
Convertible Notes payable		$ 17,037		17,037
September 30, 2019 [Member] | Convertible Notes Payable [Member]
Convertible note conversion price		$ 0.005
Beneficial conversion feature		$ 526
Convertible note bearing interest		35.00%
Operating expenses		$ 526
Convertible Notes payable		$ 526		526
December 31, 2019 [Member] | Convertible Notes Payable [Member]
Convertible note conversion price		$ 0.005
Beneficial conversion feature		$ 18,892
Convertible note bearing interest		35.00%
Operating expenses		$ 18,892
Convertible Notes payable		$ 18,892		18,892
March 31, 2020 [Member] | Convertible Notes Payable [Member]
Convertible note conversion price		$ 0.005
Beneficial conversion feature		$ 5,834
Convertible note bearing interest		35.00%
Operating expenses		$ 5,834
Convertible Notes payable		$ 5,834		5,834
June 30, 2020 [Member] | Convertible Notes Payable [Member]
Convertible note conversion price		$ 0.001
Beneficial conversion feature		$ 2,000
Convertible note bearing interest		35.00%
Operating expenses		$ 2,000
Convertible Notes payable		$ 2,000		$ 2,000
April 1, 2018 - 1 and 2 [Member] | Convertible Notes Payable [Member]
Convertible note conversion price		$ 0.01
Beneficial conversion feature		$ 20,000
Convertible note bearing interest		45.00%
Convertible promissory note		$ 20,000
Patent purchase		$ 10,000

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
RELATED PARTY TRANSACTIONS (Details Narrative)
Operating expenses	$ 3,622	$ 13,412
Non-interest-bearing loan	$ 3,840

EQUITY (Details Narrative)

EQUITY (Details Narrative) - $ / shares	Sep. 30, 2020	Jun. 30, 2020	Jun. 30, 2019
EQUITY (Details Narrative)
Preferred stock, shares authorized	90,000,000	90,000,000	90,000,000
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, shares par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares issued	59,423,598	59,423,598	59,423,598
Common stock, shares outstanding	59,423,598	59,423,598	59,423,598